Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (211-220 of 431) with videos related to

Pageof 44
Sort By:
Therapeutics and Clinical Risk Management|July 7, 2012
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumabAthanasios D Anastasilakis, Konstantinos A Toulis, Stergios A Polyzos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2013
Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trialAthanasios D Anastasilakis, Stergios A Polyzos, Athina Gkiomisi, et al.
Metabolism: Clinical and Experimental|October 22, 2013
Irisin in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Maturitas|April 9, 2021
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerationsStergios A Polyzos, Athanasios D Anastasilakis, Zoe A Efstathiadou, et al.
Endocrine|October 7, 2020
Correction to: A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatmentZoe A Efstathiadou, Charilaos Kostoulas, Stergios A Polyzos, et al.
Hormones (Athens, Greece)|April 19, 2016
Prevalence and determinants of type 2 diabetes mellitus in a Greek adult populationSofia Tsirona, Fotis Katsaros, Alexandra Bargiota, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2014
The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrheaJoo-Pin Foo, Stergios A Polyzos, Athanasios D Anastasilakis, et al.
Annals of Hepatology|August 6, 2016
Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Vaia Polymerou, et al.
Endocrine|October 23, 2025
Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver diseaseLeonidas H Duntas, Stergios A Polyzos, Ulrike Gottwald-Hostalek, et al.
Metabolism: Clinical and Experimental|March 11, 2020
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitisStergios A Polyzos, Eun Seok Kang, Chrysoula Boutari, et al.
Pageof 44

Showing results (211-220 of 431) with videos related to

Sort By:
Pageof 44
Therapeutics and Clinical Risk Management|July 7, 2012
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumabAthanasios D Anastasilakis, Konstantinos A Toulis, Stergios A Polyzos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2013
Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trialAthanasios D Anastasilakis, Stergios A Polyzos, Athina Gkiomisi, et al.
Metabolism: Clinical and Experimental|October 22, 2013
Irisin in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Maturitas|April 9, 2021
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerationsStergios A Polyzos, Athanasios D Anastasilakis, Zoe A Efstathiadou, et al.
Endocrine|October 7, 2020
Correction to: A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatmentZoe A Efstathiadou, Charilaos Kostoulas, Stergios A Polyzos, et al.
Hormones (Athens, Greece)|April 19, 2016
Prevalence and determinants of type 2 diabetes mellitus in a Greek adult populationSofia Tsirona, Fotis Katsaros, Alexandra Bargiota, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2014
The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrheaJoo-Pin Foo, Stergios A Polyzos, Athanasios D Anastasilakis, et al.
Annals of Hepatology|August 6, 2016
Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Vaia Polymerou, et al.
Endocrine|October 23, 2025
Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver diseaseLeonidas H Duntas, Stergios A Polyzos, Ulrike Gottwald-Hostalek, et al.
Metabolism: Clinical and Experimental|March 11, 2020
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitisStergios A Polyzos, Eun Seok Kang, Chrysoula Boutari, et al.
Pageof 44